stars 1 stars 2 stars 3

At Chromocare, our passion is to advance the practice of medicine by making personalized care available to healthcare providers everywhere. Our goal is to provide broad access to reliable and affordable diagnostic testing, giving every physician the ability to decrease adverse drug reactions, lower costs and improve outcomes for their patients. Chromocare launched The Genetic Assisted Prescribing (GAP) Test to enable healthcare providers to replace the standard “trial and error” prescribing method with a more efficient, genetically informed treatment plan unique to each patient. The GAP Test is the most comprehensive drug compatibility test on the market and Chromocare is an emerging leader in the field of pharmacogenetic testing. To learn more abut how Chromocare is leading the way in precision medicine visit www.TheGAPTest.com

ChromoCare Questions

The ChromoCare annual revenue was $3 million in 2026.

ChromoCare is based in New Albany, Ohio.

The NAICS codes for ChromoCare are [62, 6215, 621, 62151].

The SIC codes for ChromoCare are [80, 807].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users